Intervju med JS Security VD Hampus Nyström

Comment

2024-10-07

Comment on Pharma Equity Group’s Directed Share Issue to a Premium

Equity research report

2024-09-05

ODI Pharma

Comment

2024-08-29

Comment on ODI Pharma’s Quarterly Report

Equity research report

2024-08-29

STENOCARE Q2-24

Comment

2024-08-22

Comment on STENOCARE’s Q2-report Report 2024